News | Breast Imaging | March 02, 2017

Volpara Solutions Showcases Volpara Enterprise 2.0 Software at ECR 2017

Research presented at ECR demonstrates how software helps breast imaging providers deliver high-quality, personalized breast screening

Volpara Solutions, Volpara Enterprise 2.0 software, breast imaging, screening, ECR 2017

March 2, 2017 — Volpara Solutions announced the European launch of Volpara Enterprise 2.0 software, which helps breast imaging facilities deliver high-quality, personalized breast screening. The software was launched at the European Congress of Radiology (ECR) meeting, March 1-5, 2017, in Vienna, Austria.

Volpara Enterprise software delivers key performance indicators (KPIs) for hundreds of performance and quality metrics, including patient positioning, compression and equipment utilization. The software provides continuous quality assurance and performance monitoring through dynamic, interactive dashboards, feeding ConstantQuality metrics that are updated with every mammography or tomosynthesis (3-D mammography) exam. The Microsoft Azure-based solution is fully integrated with VolparaDensity software.

Designed to support large or small enterprises, Volpara Enterprise software enables breast centers to perform rapid quality control checks that help optimize the productivity and efficiency of imaging resources. This in turn helps decrease costs through the reduction of retakes, increases employee effectiveness and enhances the patient experience.

Updates to VolparaEnterprise 2.0 software include:

  • New infographics and analytics tools to help improve understanding of resource utilization and performance and provide better understanding of the patient population and referral patterns;
  • The new technologist dashboard enables each radiographer to monitor her own performance and self-train to fix positioning and compression problems;
  • The lead radiographer now sees a Quality Quadrant diagram that summarizes patient positioning and compression performance by each radiographer, helping to identify training opportunities; and
  • The broader use of infographics on each new role-specific landing page makes data quicker and easier to summarize and interpret. 

“Adding VolparaEnterprise software has enabled us to implement new quality processes that will help ensure that every woman’s mammogram is the best that we can offer. Being able to pull data that has been hidden, we’re able to improve the practice’s efficiencies and effectiveness, which will help improve outcomes. We owe that to our patients,” said Kathy Schilling, M.D., medical director, Boca Raton Regional Hospital’s Christine E. Lynn Women’s Health & Wellness Institute in Florida.

Volpara Solutions is showcasing its entire suite of quantitative breast imaging tools at ECR.

The ability of analytics data from VolparaEnterprise software to help maintain accuracy and consistent quality in breast screening is the focus of numerous abstracts and educational sessions accepted for presentation at the ECR, including:

  • “Large variation in mammography compression internationally.” This poster presents an overview of breast compression across 15 countries from Australasia, Europe, and North and South America. There is a wide variation in compression between countries, which may arise both from patient-specific differences and disparities in the compression behavior of the technologists. Standardized monitoring of compression, such as done with VolparaEnterprise, can help to reduce such discrepancies, according to the company;
  • “Determination of adequate breast tissue visualisation using an automated posterior nipple line measure.” This poster describes automated measurement of the posterior nipple line (PNL). Good breast positioning is crucial for optimal cancer detection, but difficult to assess manually. The automated method proved robust in comparison to gold-standard manual measurement of the PNL and provides an important quality metric to monitor operator performance; and
  • “Grade, size, invasive status and breast density of screen-detected and interval cancers in breast screening in the U.K.”  This analysis of 3,771 U.K. women reveals that women presenting with interval cancers have a Volpara Density Grade that is 2.1 percent higher than women with screen-detected cancers. Interval cancers arise between regular mammography exams and tend to be aggressive and have a poor prognosis. Interval cancers also prove to be of higher grade, larger size and are more likely to be invasive, according to the study.

For more information: www.volparasolutions.com

Related Content

DCIS, ductal carcinoma in situ, radiation therapy, survival benefit, Brigham and Women's Hospital study

Image courtesy of Barco

News | ASTRO | October 21, 2018
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservatio
Explaining the Mammography Quality Standards Act
Feature | Mammography | October 16, 2018
The Mammography Quality Standards Act (MQSA) was enacted to improve the quality of mammography and ensure that all...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
"Where's My Mammogram?" Campaign Helps Women Own Breast Health Records
News | Breast Imaging | October 10, 2018
October 10, 2018 — Mammosphere launched “Where’s My Mammogram?,” a public service campaign to help women obtain copie
DenseBreast-info.org Launches European Expansion
News | Breast Density | October 10, 2018
DenseBreast-info.org (DB-I) announced the launch of its international expansion for European medical providers. The...
X-ray Mammography Adoption to Skyrocket for Breast Cancer Detection
News | Mammography | October 08, 2018
Highly populated countries have traditionally been slow adopters of non-conventional business models, but a new Frost...
Cullman Regional Medical Center

Cullman Regional Medical Center (Alabama) is a 145-bed medical center serving more than 175,000 residents in a six-county area and recognized as one of the region’s finest medical facilities.

Sponsored Content | Case Study | PACS | October 05, 2018
When Cullman Regional Medical Center in Alabama decided to switch from 2-D
Feature | Mammography | October 05, 2018 | By Jeff Zagoudis
“Patient-centered care” is a popular term among those in the healthcare industry in the 21st century. It means the...
Feature | Breast Imaging | October 04, 2018 | By Tracy Accardi
It has been nearly eight years since the world’s first digital breast tomosynthesis (DBT) mammography technology was...
Leica Biosystems Launches MammoPort Specimen Containment and Transport System
Technology | Breast Biopsy Systems | October 03, 2018
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system...